It is marketed under brand names such as Wegovy, specifically for weight management, and Ozempic, initially approved for type 2 diabetes
pharmacy, peptide therapy carries the same safety expectations as other prescription treatments
KLOW is an unapproved research blend of GHK-Cu (a cosmetic copper tripeptide), BPC-157 and TB-500 (research peptides supported by preclinical/animal data and prohibited in sport by WADA), and KPV (a preclinical anti-inflammatory tripeptide)
Vitamin B12 is listed for professional research use with an emphasis on documentation, compound identification, research applications, storage awareness, and third-party testing transparency
The influence of probiotics on the firmicutes/bacteroidetes ratio in the treatment of obesity and inflammatory bowel disease
Long-term treatment of galactorrhoea and hypogonadism with bromocriptine